ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Collegium Pharmaceutical Inc

Collegium Pharmaceutical Inc (COLL)

29,96
-0,45
(-1,48%)
Geschlossen 24 November 10:00PM
29,96
0,01
(0,03%)
Nach Börsenschluss: 10:25PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
29,96
Gebot
28,85
Fragen
32,00
Volumen
387.829
29,80 Tagesbereich 30,755
25,16 52-Wochen-Bereich 42,2873
Marktkapitalisierung
Handelsende
30,41
Handelsbeginn
30,42
Letzte Trade
5
@
29.05
Letzter Handelszeitpunkt
Finanzvolumen
US$ 11.695.740
VWAP
30,157
Durchschnittliches Volumen (3 Mio.)
404.932
Ausgegebene Aktien
22.300.043
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
13,87
Gewinn pro Aktie (EPS)
2,16
Erlöse
566,77M
Nettogewinn
48,16M

Über Collegium Pharmaceutical Inc

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is desi... Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Richmond, Virginia, USA
Gegründet
-
Collegium Pharmaceutical Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker COLL. The last closing price for Collegium Pharmaceutical was US$30,41. Over the last year, Collegium Pharmaceutical shares have traded in a share price range of US$ 25,16 to US$ 42,2873.

Collegium Pharmaceutical currently has 22.300.043 shares in issue. The market capitalisation of Collegium Pharmaceutical is US$678,14 million. Collegium Pharmaceutical has a price to earnings ratio (PE ratio) of 13.87.

COLL Neueste Nachrichten

Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...

Collegium Reports Record Third Quarter 2024 Financial Results

– Generated Record Q3’24 Net Revenue of $159.3 Million, Up 17% Year-over-Year, Driven by Record Belbuca® Revenue of $53.2 Million and Record Xtampza® ER Revenue of $49.5 Million – – Achieved...

Collegium Appoints Vikram Karnani as Chief Executive Officer

STOUGHTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

STOUGHTON, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.6-1.9633507853430.5630.9528.9752382329.74843207CS
4-4.51-13.083841021234.4735.9528.9747472331.86968302CS
12-8.65-22.403522403538.6142.287328.9740493235.68452074CS
26-4.56-13.209733487834.5242.287328.9744307434.69928737CS
524.2716.62125340625.6942.287325.1644310734.35143536CS
15610.9457.518401682419.0242.287314.0436662026.62335511CS
26010.7255.717255717319.2442.28731338252024.29786624CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PDYNPalladyne AI Corporation
US$ 4,59
(129,50%)
83,07M
QMCOQuantum Corporation
US$ 9,11
(126,62%)
39,48M
NANano Labs Ltd
US$ 8,26
(89,02%)
2,03M
XCURExicure Inc
US$ 18,60
(71,27%)
4,59M
SKKSKK Holdings Limited
US$ 1,75
(59,09%)
107,47M
AMIXAutonomix Medical Inc
US$ 6,21
(-54,07%)
946,09k
CETXCemtrex Inc
US$ 0,1146
(-41,74%)
24,39M
MSWMing Shing Group Holdings Ltd
 5,90
(-35,52%)
417,08k
RMSGReal Messenger Corporation
US$ 3,09
(-26,25%)
313,51k
ENSCEnsysce Biosciences Inc
US$ 0,4414
(-25,49%)
4M
ELABElevai Labs Inc
US$ 0,0201
(-0,50%)
425,38M
NVDANVIDIA Corporation
US$ 141,95
(-3,22%)
236,51M
SMCISuper Micro Computer Inc
US$ 33,15
(11,62%)
159,61M
VRPXVirpax Pharmaceuticals Inc
US$ 0,5501
(-6,72%)
159,39M
SOUNSoundHound AI Inc
US$ 8,24
(18,05%)
107,91M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock